Journal
SURGERY OPEN SCIENCE
Volume 2, Issue 2, Pages 75-80Publisher
ELSEVIER
DOI: 10.1016/j.sopen.2019.12.003
Keywords
-
Categories
Funding
- National Center for Advancing Translational Sciences of the National Institutes of Health [UL1TR002538]
Ask authors/readers for more resources
Background: Transversus abdominis plane block with liposomal bupivacaine has been studied as an effective method of reducing the need for postoperative opioids and increasing same-day discharge rates. However, less is known about the cost-effectiveness of this strategy relative to opioids alone for hernia repair. We performed an economic evaluation of these strategies using a computer simulation model. Methods: A decision tree was constructed to determine cost-effectiveness as measured by incremental cost-effectiveness ratios per quality-adjusted life-year. Base-case costs, quality-adjusted life-year values, and probabilities were derived from published studies and Medicare fee schedules. For input parameters for which we could not find values in the published literature, we used expert opinion. A 1-month time horizon was selected to focus on the immediate postoperative period. Finally, we performed 1-way, 2-way, and probabilistic sensitivity analyses. Results: The liposomal bupivacaine transversus abdominis plane block was a dominant strategy yielding a $456.75 decrease in cost and an 0.1 increase in quality-adjusted life-years relative to opioids alone. In 1-way sensitivity analysis of cost incremental cost-effectiveness ratio, values were most sensitive to variations in the amount saved by same- day discharge and the cost of bupivacaine. In probabilistic sensitivity analyses, transversus abdominis plane strategywas cost-effective at awillingness-to-pay threshold of $50,000/quality-adjusted life-year in 94.5% of iterations and at awillingness-to-pay threshold of $100,000/quality-adjusted life-year in 97.1% of iterations. Conclusion: The use of liposomal bupivacaine transversus abdominis plane block resulted in cost savings and improved quality-adjusted life-years in base-case analyses and was cost-effective at conventional willingness-topay thresholds in the majority of iterations in probabilistic sensitivity analyses. (C) 2020 The Authors. Published by Elsevier Inc.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available